HomeMCPWorkbenchSkills
HomeWorkbenchNotificationsMe
Huagongshe Open Program:[email protected]AI access: llms.txt · MCP GuidePrivacy Policy · Terms of Service · Supportv1.7.8
  1. Home
  2. /Compound

1,1-Dimethylethyl N-(5-((4-methylphenyl)sulfonyl)-5H-pyrrolo(2,3-b)pyrazin-2-yl)carbamate

HCID 58009783
NotesReactions
Basic informationNames & identifiersPropertiesSafety & regulationChemistry & industryRelated reactionsCompound notes
Substructure searchFind similar structures

Basic information

CAS
1201187-44-1
Standard SMILES
Cc1ccc(S(=O)(=O)n2ccc3nc(NC(=O)OC(C)(C)C)cnc32)cc1
InChIKey
NTMJGYRFMXFNIC-UHFFFAOYSA-N
Molecular formula
C18H20N4O4S
Average molar mass
388.4 g/mol

Names & identifiers

Preferred name
1,1-Dimethylethyl N-(5-((4-methylphenyl)sulfonyl)-5H-pyrrolo(2,3-b)pyrazin-2-yl)carbamate
IUPAC
tert-butyl N-[5-(4-methylphenyl)sulfonylpyrrolo[2,3-b]pyrazin-2-yl]carbamate
English name
tert-butyl 5-tosyl-5H-pyrrolo[2,3-b]pyrazin-2-ylcarbamate
Molecular formula
C18H20N4O4S
Molecular weight
388.44

Names & synonyms

1201187-44-14L6GM5UL9Q1,1-Dimethylethyl N-(5-((4-methylphenyl)sulfonyl)-5H-pyrrolo(2,3-b)pyrazin-2-yl)carbamate1,1-Dimethylethyl N-[5-[(4-methylphenyl)sulfonyl]-5H-pyrrolo[2,3-b]pyrazin-2-yl]carbamateRefChem:1051823tert-butyl N-[5-(4-methylbenzenesulfonyl)-5H-pyrrolo[2,3-b]pyrazin-2-yl]carbamatetert-butyl 5-tosyl-5H-pyrrolo[2,3-b]pyrazin-2-ylcarbamatetert-Butyl (5-tosyl-5H-pyrrolo[2,3-b]pyrazin-2-yl)carbamateMFCD281297282-(Boc-amino)-5-tosyl-5H-pyrrolo[2,3-b]pyrazineCarbamic acid, N-[5-[(4-methylphenyl)sulfonyl]-5H-pyrrolo[2,3-b]pyrazin-2-yl]-, 1,1-dimethylethyl estertert-butyl N-[5-(4-methylphenyl)sulfonylpyrrolo[2,3-b]pyrazin-2-yl]carbamate
Show more names
N-[5-[(4-Methylphenyl)sulfonyl]-5H-pyrrolo[2,3-b]pyrazin-2-y...Upadacitinib Impurity 3Upadacitinib Intermediate4Upadacitinib intermediate2Upadacitinib IntermediatesIntermediate of Upadacitinib (ABT-494)tert-butyl 5-tosyl-5H-pyrrolo[2,3-b]pyrazin-2-ylcarbama
N-[5-[(4-Methylphenyl)sulfonyl]-5H-pyrrolo[2,3-b]pyrazin-2-yl]carbamic acid 1,1-dimethylethyl esterSCHEMBL1536091SCHEMBL30007018WLZ3546NTMJGYRFMXFNIC-UHFFFAOYSA-NAKOS027338442SB18104AC-31351

Database identifiers

CAS
1201187-44-1
PubChem CID
58009783
UNII
4L6GM5UL9Q

Properties

Computed structural properties

XLogP
2.8
Topological polar surface area
112 Ų
Hydrogen bond donors
1
Hydrogen bond acceptors
6
Rotatable bonds
5
Heavy atoms
27
Formal charge
0
Complexity
635

Physicochemical properties

Density
1.35 · 1.35±0.1 g/cm3(Predicted)
storage temp.
Store at Room Tem.
pka
9.45 · 9.45±0.43(Predicted)
InChI
InChI=1S/C18H20N4O4S/c1-12-5-7-13(8-6-12)27(24,25)22-10-9-14-16(22)19-11-15(20-14)21-17(23)26-18(2,3)4/h5-11H,1-4H3,(H,20,21,23)
InChIKey
NTMJGYRFMXFNIC-UHFFFAOYSA-N
SMILES
C(OC(C)(C)C)(=O)NC1=CN=C2N(S(C3=CC=C(C)C=C3)(=O)=O)C=CC2=N1
Symbol(GHS)
7 · GHS07
Signal word
Warning
Hazard statements
302 · H302-H317
Precautionary statements
280 · P280

Safety & regulation

Safety information is for reference only and does not replace the supplier’s Safety Data Sheet (SDS), applicable regulations, or professional assessment.

Safety data

Signal word
Warning
Symbol(GHS)
GHS07
Hazard statements
H302-H317
Precautionary statements
P280

Chemistry & industry

Applications · 2 items

Usestert-Butyl N-[5-(4-methylbenzenesulfonyl)-5H-pyrrolo[2,3-b]pyrazin-2-yl]carbamate is a reagent in the synthetic preparation of tricyclic heterocycles and their kinase inhibitory activity. Preparation of novel nitrogen-containing tricyclic compounds as kinase inhibitors for treating immunological and oncological conditions.

UsesTert-butyl 5-tosyl-5H-pyrrolo[2,3-b]pyrazin-2-ylcarbamate, also known as upadacitinib intermediate 2, could be used in the synthesis and property studies of upadacitinib. This compound Often used as organic synthesis intermediates and pharmaceutical intermediates. It can be used in laboratory research processes and chemical production processes.

Preparation methods · 1 item

PreparationStarting with 5-bromo-4,7-diazaindole, tert-butyl 5-tosyl-5H-pyrrolo[2,3-b]pyrazin-2-ylcarbamate was prepared through a series of substitution reactions with ammonia, p-toluenesulfonyl chloride, and tert-butyl chloroformate. This preparation process is simplified, with less demanding reaction conditions, no large amounts of byproducts, convenient operation, and uncomplicated post-processing. The product yield is significantly improved, and the reaction time is shortened under catalytic conditions, saving production costs and time, making it suitable for large-scale industrial production.

Upstream & downstream products

Upstream raw materials

N-Tosyl-5-bromo-4,7-diazaindoletert-Butyl carbamate

Suppliers100 total

Career Henan Chemica Co+86-0371-86658258 +86-13203830695 · [email protected]
济南百隆化学有限公司[email protected] · [email protected]
Shochem(Shanghai) Co.,Ltd86-21-50800795 · [email protected]
济南诚汇双达生物有限公司053158897070 15550412551
南京济宇生物科技有限公司17712667785 18068059186 · [email protected]
成都市久鼎化学技术有限公司18584079237 · [email protected]
温州共赢化学有限公司+86-0086-577-64498589 +86-15355981851 · [email protected]
武汉灵灵九生物科技有限公司15623309010
斯芬克司药物研发(天津)股份有限公司022-66211289-818 13652044576 · [email protected]
上海遐瑞医药科技有限公司+86-021-61551413 · [email protected]
T&W GROUP021-61551611 13296011611 · [email protected]
Baoji Guokang Healthchem co.,ltd+8615604608665 15604608665 · [email protected]
上海靖灏医药科技有限公司+86-21-68900963 · [email protected]
成都蓝蜻蜓生物技术有限公司028-87856149; 15208320722 · [email protected]
上海波以尔化工有限公司[email protected]
Allfluoro Pharmaceutical Company Limited+86-400-0216110 +86-15958047586 · [email protected]
梯希爱(上海)化工贸易有限公司021-61109150 · [email protected]
安庆奇创药业有限公司18061456370
凯瑞斯德生化(苏州)有限公司0512-62956066 18112603058
常州市淇奥化工有限公司0519-85607258
上海钰康生物科技有限公司+86-18930848214 +86-021-56762820 · [email protected]
上海瀚香生物科技有限公司177-54423994 17754423994 · [email protected]
成都福尔斯特医药技术有限公司028-87078428 028-87074958 · [email protected]
广州九植医药科技有限公司020-89854820 · [email protected]
江苏威凯尔医药科技有限公司025-58741518 13327700685 · [email protected]
同创医药(苏州)有限公司0512-63263366 18912765016 · [email protected]
北京中硕医药科技开发有限公司13801189771 13801208576
苏州岚云医药科技有限公司2332782371 · [email protected]
深圳振强药物研发有限公司0755-66853366 13670046396 · [email protected]
台州南峰药物研究所[email protected] 18616377689 · [email protected]
贵州易妥化学科技有限公司18628235590 · [email protected]
金瓯生物医药(南京)有限公司13000000000 · [email protected]
山东轩德医药科技有限公司0531-88803958 19862127196 · [email protected]
沧州康瑞医药科技有限公司18632776803
山东君泰药业有限公司15006412179 · [email protected]
南京恰风和医药科技有限公司025-57018978 18251899859 · [email protected]
杭州科巢生物科技有限公司0571-89081561; 10006559855
陕西缔都医药化工有限公司029-81024372 17792795018 · [email protected]
北京翔宇恒天医药技术有限公司010-88755821 13911359480;18612220856
上海缘启生物科技有限公司+86-2332782371 +86-18120098618 · [email protected]
甘肃皓天科技股份有限公司0943-6900332 17789447501 · [email protected]
上海孟善化工有限公司21-58226973 18917146209 · [email protected]
浙江泽天精细化工有限公司0571-87322520 18957127338 · [email protected]
成都赛诺宁科技有限公司28-87999436 02887999436 · [email protected]
上海皓之翔生物科技有限公司(原上海拓青化工有限公司)526763801 13301653310 · [email protected]
苏州鹏旭医药科技有限公司15850786624 · [email protected]
南京菲泓科技有限公司025-58855213 · [email protected]
湖北威德利化学试剂有限公司18327179646 · [email protected]
浙江科聚生物医药有限公司19967494293 · [email protected]
北京建强伟业科技有限公司(FUSION弗珍试剂品牌)0531-88924771 15614660963 · [email protected]

Related reactions

23 records
New reaction record
HRID 182344 reaction equation
HRID 182344As reactantTraining data from https://doi.org/10.1039/C8SC04228D (6/10)
HRID 309611 reaction equation
HRID 309611As reactantTraining data from https://doi.org/10.1039/C8SC04228D (8/10)
HRID 817332 reaction equation
HRID 817332As reactantTest data from https://doi.org/10.1039/C8SC04228D
HRID 1202683 reaction equation
HRID 1202683As reactantTraining data from https://doi.org/10.1039/C8SC04228D (5/10)
HRID 1538606 reaction equation
HRID 1538606As reactantTraining data from https://doi.org/10.1039/C8SC04228D (1/10)
HRID 1854384 reaction equation
HRID 1854384As productuspto-grants-2015_02
HRID 1854387 reaction equation
HRID 1854387As reactantuspto-grants-2015_02
HRID 1854431 reaction equation
HRID 1854431As productuspto-grants-2015_02
Page 1 of 3

Compound notes

Loading…

On this pageBasic informationNames & identifiersPropertiesSafety & regulationChemistry & industryRelated reactionsCompound notes